Summary of Compensation Arrangements for Named Executive Officers (Fiscal 2007–2008)
This document outlines the base salaries and bonuses for the named executive officers of Myriad Genetics, Inc. and its subsidiaries for fiscal years 2007 and 2008. It lists the compensation details for the President and CEO, the Presidents of Myriad Genetic Laboratories and Myriad Pharmaceuticals, the Chief Financial Officer, and the Chief Scientific Officer. The agreement specifies annual base salaries and bonuses, with a note that the Chief Scientific Officer is paid hourly and actual compensation may vary based on hours worked.
Exhibit 10.25
COMPENSATION OF NAMED EXECUTIVE OFFICERS
| Name and Position | Fiscal 2007 Base Salary ($) | Fiscal 2008 Base Salary ($) | Fiscal 2007 Bonus ($) | |||
| Peter D. Meldrum President and Chief Executive Officer | 676,500 | 727,000 | 550,000 | |||
| Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. | 465,000 | 500,000 | 350,000 | |||
| Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. | 465,000 | 500,000 | 300,000 | |||
| Jay M. Moyes Chief Financial Officer | 355,000 | 380,000 | 220,000 | |||
| Mark H. Skolnick, Ph.D. (1) Chief Scientific Officer | 480,600 | 500,000 | 150,000 |
| (1) | Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked. |
